Tag: Abbott

Abbott launches GLP Systems Track lab automation system in US

businessnewstoday- December 15, 2023

Abbott has announced the launch of its innovative lab automation solution, GLP systems Track, which has recently received approval from the U.S. Food and Drug ... Read More

Abbott secures Bigfoot Biomedical to boost diabetes care tech

businessnewstoday- September 24, 2023

Abbott has wrapped up the previously announced acquisition of Bigfoot Biomedical. The latter which is a Silicon Valley-based front-runner is celebrated for its revolutionary smart ... Read More

Abbott closes $890m acquisition of Cardiovascular Systems

businessnewstoday- April 29, 2023

Abbott has closed the previously announced $890 million acquisition of Cardiovascular Systems, Inc. (CSI), which has developed an atherectomy system for the treatment of peripheral ... Read More

Generic Pharmasec to distribute Abbott Point of Care’s products in India

businessnewstoday- May 31, 2021

Generic Pharmasec said that it has signed an agreement with Abbott Point of Care (APOC) for the distribution, marketing, and promotion of the latter’s full ... Read More

AstraZeneca India scraps Dapagliflozin distribution deal with Abbott

pallavi123- May 30, 2021

AstraZeneca Pharma India (AstraZeneca India) said that it has scrapped its distribution agreement with Abbott Healthcare pertaining to its Type 2 diabetes drug Dapagliflozin in ... Read More

Abbott gets FDA EUA for COVID-19 antibody blood test on Alinity i system

pharmanewsdaily- May 12, 2020

Abbott has been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its SARS-CoV-2 IgG lab-based serology blood test, a ... Read More

Abbott ID NOW COVID-19 test gets FDA nod to detect coronavirus in 5 mins

pharmanewsdaily- March 28, 2020

Abbott ID NOW COVID-19 test : Medical device company Abbott has been granted Emergency Use Authorization (EUA) for its five-minute novel coronavirus diagnostic test from ... Read More

CATALYST clinical trial : FDA approves Abbott’s trial of Amplatzer Amulet device in AF

pharmanewsdaily- February 4, 2020

Abbott has been granted approval from the US Food and Drug Administration (FDA) for the CATALYST clinical trial to assess its Amplatzer Amulet Left Atrial ... Read More